Abstract
Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease (P9-9.011)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have